TP53 and cancer: Mouse models have been developed to dissect the interplay between mutant p53 and oncogenic Ras in human cancer and have demonstrated that the presence of both genetic alterations give rise to highly invasive and metastatic tumors associated with a decrease in survival [43]–[45].